Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.

Arterioscler Thromb Vasc Biol · 2018 · PMC6039422 · PMID 29880491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Lamon-Fava et al 39 reported that atorvastatin significantly reduced TRL-apoB-48 concentration under constant feeding conditions in 9 patients with combined hyperlipidemia by increasing the FCR and reducing the PR of TRL-apoB-48, but these kinetic parameters failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.